7-150947477-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.3003G>A(p.Trp1001*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000238.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.3003G>A | p.Trp1001* | stop_gained | Exon 13 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00 AC: 0AN: 190766 AF XY: 0.00
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1427632Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 706916
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome 2 Pathogenic:1
- -
not provided Pathogenic:1
Has been reported in individuals with LQTS (PMID: 11854117, 23995044); Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest the p.(W1001*) variant results in a truncated protein and significant reduction in channel current properties (PMID: 12021266); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 11686910, 11854117, 23995044, 17576861, 12021266) -
Long QT syndrome Pathogenic:1
This sequence change creates a premature translational stop signal at codon 1001 (p.Trp1001*) of the KCNH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNH2 are known to be pathogenic. There are two different nucleotide changes (c.3002G>A and c.3003G>A) that result in the same amino acid change to a stop codon. The variant c.3002G>A has been classified as pathogenic (Invitae database). This protein change has been reported in the literature in individuals affected with long QT syndrome (PMID: 12021266, 26846766, 11854117). Experimental studies have shown that this nonsense change (p.Tryp1001*) results in reduced mRNA levels due to nonsense-mediated decay and the resulting protein is truncated, which results in a channel with reduced current amplitude (PMID: 17576861, 12021266). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at